Italian Stock Exchange, commentary from the session of 24 April 2024

Italian Stock Exchange, commentary from the session of 24 April 2024
Descriptive text here

ENI in negative territory, after the release of the quarterly report. STM’s leap stands out. Salcef Group is in the spotlight at the STAR segment.

The major Italian Stock Exchange indices and the main European financial markets they record fractional progressafter the increases achieved in the previous session.

At 10.20 am FTSEMib recorded an increase of 0.18% to 34,426 points, while the FTSE Italia All Share it earned 0.16%. Plus sign also for the FTSE Italia Mid Cap (+0.08%) and for the FTSE Italia Star (+0.32%).

The bitcoin it stands at over 66,500 dollars (less than 62,500 euros).

The Btp-Bund spread consolidates beyond 130 points, with the yield of the ten-year BTP which rose above 3.85%.

L’EUR it fell below $1.07.

ENI leaves 0.98% on the ground at 15.368 euros. The company announced its financial results for the 1st quarter of 2024, a period in which the oil giant was affected by the decline in natural gas prices. Management provided financial and operational guidance for the full year of 2024.

STM recorded an increase of 6.15% to 39.55 euros, on the eve of the release of the quarterly results. The Italian-French group benefits from the results of Texas Instruments, which finished the first three months of 2024 with a profit per share significantly higher than the analysts’ consensus.

At the STAR segment in the spotlight Salcef Group: the title earn 18.8% at 26.25 euros. The shareholders of Finhold (majority shareholder of the company) and the funds managed by Morgan Stanley Infrastructure Partners have signed a binding purchase and sale and investment agreement aimed at investing in the listed company. Following the closing of the operation, a mandatory public takeover offer will be promoted aimed at the delisting of Salcef Group shares from Piazza Affari. The price of the tender offer will be 26.55 euros per share (cum dividend), corresponding to a 20% premium compared to the official price of the stock in the session of 23 April 2024.

Among companies with smaller capitalization, focus is still on Bioera, after the rally recorded in the previous two sessions. The stock fails to make a price due to excessive decline, with a theoretical drop of 20.8%.

Tags:

 
For Latest Updates Follow us on Google News
 

PREV Ftse Mib on an important support
NEXT Bonuses for families to request with 730/2024, here’s what they are